Skip to main content

Table 2 Mean level of satisfaction with each decision box of participating clinicians measured with a 5-point smiley-faces rating scale ranging from 1 (sad face) to 5 (smiling face)

From: Feasibility of a randomized controlled trial to evaluate the impact of decision boxes on shared decision-making processes

Decision box clinical topics (abbreviations) Mean level of satisfaction, range 1–5, 5 indicating higher satisfaction (± SD) n
The serum integrated test to screen women for fetal trisomy 21 (Prenatal) 4.40 (0.85) 67
The prostate-specific antigen test to screen men for prostate cancer (PSA) 4.18 (0.87) 51
Statins for primary prevention of cardiovascular disease (Statins) 4.15 (0.78) 56
Acetylsalicylic acid for primary prevention of cardiovascular disease (ASA) 4.08 (0.94) 67
The fecal occult blood test to screen for colorectal cancer (FOBT) 4.07 (0.99) 61
The BRCA1/2 gene mutation test to evaluate the risks of breast and ovarian cancer (BRCA) 4.05 (0.94) 63
Cholinesterase inhibitors to reduce the symptoms of Alzheimer’s disease (ChEIs) 4.04 (0.99) 74
Bisphosphonates to prevent osteoporotic fractures in postmenopausal women (OSTEO) 3.98 (0.83) 57